Member Info for Wassatt

We do seem to watch the same thing
Yeah he certainly finds a way to spoil every attempt at relationships

Well at least we can still post about it

I can't see or understand why that's lower!!!!!!

I'd like to see the anti one recover some losses, hopefully through buyers seeing a good opportunity

Over to you in the early movers, up or down !!!!!

Asian shares recover as China outlines 2019 policy plans

https://finance.yahoo.com/news/asian-shares-recover-china-outlines-065056716.html?.tsrc=applewf

Well that's my take (if minor) on today's news
I'm not sure whether is helps anyone but hey ....

Could see movement today following this award

"We are thrilled to announce yet another commercial launch for our Iris multiscreen technology, this time with One Communications in Bermuda. We look forward to seeing this new location enjoy the ultimate viewing experience provided by our Iris multiscreen technology and working alongside ATNi for further upcoming projects."

One to watch IMO, as if the second order comes to fruition then good SP movement will follow

genedrive has the first to market point-of-need molecular test for HCV, a strong commercial platform, and a clear strategy to deliver revenue growth. genedrive has secured four registrations for the Genedrive® HCV ID Kit, is gaining recognition in the marketplace and is currently involved in a number of country specific commercial initiatives. The US Department of Defense order has made a significant contribution to revenue in the period and with the recently received additional order we are hopeful that this momentum will continue."

Looks good for the future

Recent years have seen the emergence of a remarkable new class of cell-based therapies targeting many indications - from ultra-rare diseases affecting a handful of patients to some of the most common forms of cancer. Our team at MaxCyte is proud to be at the forefront of this therapeutic revolution, enabling pioneers in the industry to develop these new treatments as well as powering CARMA, MaxCyte's own therapeutic development program.

Good figures being oredicted for 2019, growth looks very positive

"2018 was an exceptional operational year for Eland, with net production increasing some 60% from the start of the year to over 13,000 bopd by the year end, a record for the Company and for the OML 40 licence. Moreover, the Ubima field tested at combined rates of up to 1,400 bopd net to Eland and this is expected to enter commercial production in H1 2019. Gbetiokun will also provide a step-change in production as we forecast over 6,700 bopd net to the Company following commencement of the extended well test in Q1 2019.

25% increase year on year, that's amazing

We are very pleased to continue to deliver positive production results, as evidenced by our 25% year over year oil sales growth. As we move into 2019, we are seeking to prioritize the exciting exploration opportunities we have identified at Ortoire together with the predictable development drilling inventory we have amassed to date."

Positive figs, happy locals 32% reduction in net debt hmmmmmm

We have made strong progress during the year and I am incredibly grateful to everyone in the business for their expertise and commitment to our customers. As a team, we remain focused on the execution of our growth strategy and I'm pleased to report that we expect to be comfortably in line with management's expectations, with the standout financial highlight being a 32% reduction in net debt.

Well reading between the lines I would suggest adding to watchlist

"2018 has been a standout year for CloudCall in terms of new product innovation and investment in our platform, and our sales and marketing capabilities. As with most SaaS businesses, there is always a lag between making these investments and the resulting revenue growth, so I am delighted that we are now starting to see tangible acceleration in customer orders and user growth. As we exit 2018, I still strongly believe that the investments we have made will be most impactful in 2019 and should underpin further acceleration.

Has performed well, the natives will be happy today IMO

During the period, Trinity continued to build on the momentum achieved during the first three quarters in 2018 by delivering further growth in profitable production. This was enabled by the continuation of its fully funded onshore drilling programme with the six new wells coming on stream on time and below budget thus contributing to a strong upswing in production during the period.

Could be one to add to your watchlist.

The Group performed strongly in the year following initiatives both to grow Kape's product offering and user base, and to generate higher margin recurring revenues.

Again good figures fir 2018, should see positive movement

"We are delighted to be reporting yet another great set of financial and operational results and would like to say a very big thank you to all our team and customers. We remain firmly focused on continuing to provide our customers with great fashion at unbeatable value. The global growth opportunity is significant and we will be addressing it in a controlled way - investing in our proposition, operations and infrastructure to capitalise on the opportunity."

Doubling sales during 2018 is a great achievement, should see a lift

"2018 showed continued growth in the sale of Mevalone in southern Europe despite low disease pressure attributed to another hot, dry summer. We are encouraged by the doubling of Mevalone sales during the year as this reflects the increasing acceptance of Mevalone in the market, the optimised product positioning initiated by our partners and its adoption and continued use by growers.

Good news if you hold, should see positive movement

After many months of hard and patient work, the Company has managed to crystalize two deals which provide a platform to transform Orosur: an agreement in Colombia with Newmont which provides the structure, financing and technical support to build a significant project in Anzá, and a significant vote of confidence from an impressive majority of 70% of the Loryser creditors to our proposed plan to reach a fair and balanced solution to the re-organisation proceedings in Uruguay. We are delighted with these two milestones and very aware of the work in front of us and our commitment to deliver on both agreements.”

Good morning all